Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (81-90 of 334) with videos related to

Pageof 34
Sort By:
Plos One|February 15, 2013
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cellsBastian Schilling, Malgorzata Harasymczuk, Patrick Schuler, et al.
International Journal of Cancer|February 2, 2006
Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?Sandra R Reynolds, Irene J Vergilis, Michael Szarek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic miceLiaomin Peng, Eric Ko, Wei Luo, et al.
Cancer Research|October 3, 2008
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculaturePaulo Cesar Maciag, Matthew M Seavey, Zhen-Kun Pan, et al.
Acta Neuropathologica|June 2, 2007
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?Matthias Mehling, Perikles Simon, Michel Mittelbronn, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanismsChien-Chung Chang, Michael Campoli, Wei Luo, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2007
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaAkash M Mehta, Ekaterina S Jordanova, Gemma G Kenter, et al.
European Journal of Immunology|February 21, 2003
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligationPaola Contini, Massimo Ghio, Alessandro Poggi, et al.
Oncotarget|February 11, 2016
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cellsSofia R Gameiro, Anthony S Malamas, Kwong Y Tsang, et al.
Cancer Research|September 20, 2006
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic markerTakeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii, et al.
Pageof 34

Showing results (81-90 of 334) with videos related to

Sort By:
Pageof 34
Plos One|February 15, 2013
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cellsBastian Schilling, Malgorzata Harasymczuk, Patrick Schuler, et al.
International Journal of Cancer|February 2, 2006
Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?Sandra R Reynolds, Irene J Vergilis, Michael Szarek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic miceLiaomin Peng, Eric Ko, Wei Luo, et al.
Cancer Research|October 3, 2008
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculaturePaulo Cesar Maciag, Matthew M Seavey, Zhen-Kun Pan, et al.
Acta Neuropathologica|June 2, 2007
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?Matthias Mehling, Perikles Simon, Michel Mittelbronn, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanismsChien-Chung Chang, Michael Campoli, Wei Luo, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2007
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaAkash M Mehta, Ekaterina S Jordanova, Gemma G Kenter, et al.
European Journal of Immunology|February 21, 2003
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligationPaola Contini, Massimo Ghio, Alessandro Poggi, et al.
Oncotarget|February 11, 2016
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cellsSofia R Gameiro, Anthony S Malamas, Kwong Y Tsang, et al.
Cancer Research|September 20, 2006
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic markerTakeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii, et al.
Pageof 34